• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOLTA MEDICAL INC THERMAGE CPT SYSTEM; ELECTROSURGICAL,CUTTING & COAGULATION & ACC.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOLTA MEDICAL INC THERMAGE CPT SYSTEM; ELECTROSURGICAL,CUTTING & COAGULATION & ACC. Back to Search Results
Model Number TTNS3.00E4-900
Device Problem Insufficient Information (3190)
Patient Problems Burn(s) (1757); Erythema (1840); Blister (4537)
Event Date 11/27/2021
Event Type  Injury  
Manufacturer Narrative
The treatment tip was discarded by the treatment facility and is therefore not available for return and evaluation.The lot number is currently unknown so no batch record analysis is possible.Based on all available information no conclusion can be drawn and no cause established.
 
Event Description
A patient called to report that they experienced blisters on their right cheek immediately following a thermage cpt treatment they received approximately 2 months prior to reporting the event.The patient indicated they went to the hospital for treatment, where they were prescribed epidermal growth factor.The patient reported that despite that treatment and another laser therapy they still have hyperpigmented lesions on the burned area.The treating doctor was contacted to provide clinical information related to this event.The doctor reported that they performed a full face thermage cpt treatment at a maximum power level of 3.5.Ample coupling fluid was used during treatment, and it was reported the treatment tip was inspected prior to and throughout the treatment with no abnormalities noted.The doctor noted that they treated the left face and forehead first with no issue, but the patient reported increased pain when the right side of the face was treated.The doctor reduced the power level at the time of the reported pain and re-inspected the treatment tip without noting any issue.The treatment was completed at the lower power level.Following treatment, the doctor observed erythema and blisters forming on the right side of the face.The doctor then re-inspected the treatment tip and noted that the edge of the tip was broken.The patient was administered an unidentified burn ointment and epidermal growth ointment, as well as undergoing an ipl treatment.The patient is currently under treatment in a medical center.The current status of the patient is reported as hyperpigmentation and the possibility of permanent scarring is unknown but noted as unlikely.
 
Manufacturer Narrative
The treatment tip was discarded by the treatment facility and is therefore not available for return and evaluation.The lot number is currently unknown so no batch record analysis is possible.Based on all available information no conclusion can be drawn and no cause established.
 
Event Description
A patient called to report that they experienced blisters on their right cheek immediately following a thermage cpt treatment they received approximately 2 months prior to reporting the event.The patient indicated they went to the hospital for treatment, where they were prescribed epidermal growth factor.The patient reported that despite that treatment and another laser therapy they still have hyperpigmented lesions on the burned area.The treating doctor was contacted to provide clinical information related to this event.The doctor reported that they performed a full face thermage cpt treatment at a maximum power level of 3.5.Ample coupling fluid was used during treatment, and it was reported the treatment tip was inspected prior to and throughout the treatment with no abnormalities noted.The doctor noted that they treated the left face and forehead first with no issue, but the patient reported increased pain when the right side of the face was treated.The doctor reduced the power level at the time of the reported pain and re-inspected the treatment tip without noting any issue.The treatment was completed at the lower power level.Following treatment, the doctor observed erythema and blisters forming on the right side of the face.The doctor then re-inspected the treatment tip and noted that the edge of the tip was broken.The patient was administered an unidentified burn ointment and epidermal growth ointment, as well as undergoing an ipl treatment.The patient is currently under treatment in a medical center.The current status of the patient is reported as hyperpigmentation and the possibility of permanent scarring is unknown but noted as unlikely.
 
Event Description
Available pictures were provided and reviewed.In the first picture, marked as immediately post procedure, a large area of inflammation is visible on one side of the patient face.The second picture, marked as three days post procedure, blisters, crusts, and post inflammatory hyperpigmented areas are visible on one side of the patient face.In the third picture, marked as one month post procedure, inflammation and blisters are recovered with visible hyperpigmented areas.
 
Manufacturer Narrative
New clinical information was received and entered into section b5.
 
Manufacturer Narrative
Correction to h5: changed from "no" to "yes".The data logs were reviewed however did not include data from the reported treatment date.The tip was not returned for evaluation.According to thermage cpt user manual, burns and pigment changes are known potential reactions to treatment.The procedure may produce heating in the upper layers of the skin, causing burns and subsequent blister and scab formation.There is a small chance of scar formation.Application of topical steroidal or antibiotic preparations may be of benefit.In the rare instance of a burn that results in a scar, the scar will probably be very small and respond readily to removal with a laser device.No solta serial/lot number was reported for this event.The trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.Based on the available information, no causal factors can be determined and no conclusions can be drawn.No corrective action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMAGE CPT SYSTEM
Type of Device
ELECTROSURGICAL,CUTTING & COAGULATION & ACC.
Manufacturer (Section D)
SOLTA MEDICAL INC
11720 n creek pkwy north
suite 100
bothell WA 98011
Manufacturer (Section G)
SOLTA MEDICAL INC
11720 n creek pkwy north
suite 100
bothell WA 98011
Manufacturer Contact
jennifer gamet
1400 goodman st n
rochester, NY 14609
5853386853
MDR Report Key13552435
MDR Text Key286009682
Report Number3011423170-2022-00014
Device Sequence Number1
Product Code GEI
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K132431
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 01/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/17/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTTNS3.00E4-900
Device Catalogue NumberTTNS3.00E4-900
Device Lot Number222
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received03/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age43 YR
Patient SexFemale
-
-